-
3D QSAR Studies for a Series of Trypanosoma cruzi Dihydroorotate Dehydrogenase Inhibitors
Vol. 1, 2019 -109014 -
Structure-activity relationships of sulfonamides derived from carvacrol as new agents for the treatment of Alzheimer's disease
Vol. 1, 2019 -109029 -
Hybridization Approach for Drug Design in Anti-leishmanial Cinnamoylhydrazones
Vol. 1, 2019 -111905 -
Carbamoylimidazoles as Potent Cruzain Inhibitors with in Vitro and in Vivo Trypanocidal Activity: a Structure–Based Drug Design Approach
Vol. 1, 2019 -108992 -
Antitrypanosomal aminobenzimidazoles: hit to lead expansion of new chemical entities against Trypanosoma cruzi and Leishmania infantum
Vol. 1, 2019 -108967
Publications in other proceedings
-
BCNP 2023
Antiprotozoal potential of the alkaloids isolated from the Amazon plant Malouetia tamaquarina (Apocynaceae) and its endophytes against Neglected Tropical Diseases (NTDs).
-
BrazMedChem 2022
Antitrypanosomal Benzoxazinone Series: Hit-to-Lead Campaign and Multiparametric Optimization
-
BrazMedChem 2022
Indoles Hit-to-Lead for Chagas Disease: Lessons Learned within the LOLA consortium
-
FAPESP
Discovering the potential of the secondary metabolites from Malouetia tamaquarina (Apocynaceae) and its endophytes against Neglected Tropical Diseases (NTDs)
-
BCNP 2021
Identification of active compounds against pathogens from Streptomyces isolated from fungus-growing ants
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
